"‘Drug Cocktails’ Could Strengthen Targeted Cancer Therapies"
Researchers have identified that certain drugs taken in combination, ‘drug cocktails,’ help therapies to target and attack cancer more efficiently. The team for the Icahn School of Medicine at Mount Sinai discovered that side effects lessened when using certain ‘drug cocktails.’ “Targeted therapies have revolutionized cancer treatment by targeting fewer components within a human cell, thereby promising better efficacy and lower side effects compared to chemotherapy,” said Tirtha K. Das, MD, assistant professor of cell, developmental and regenerative biology at the Icahn School of Medicine at Mount Sinai. “Our work addresses the central question faced by physicians who treat cancer patients: how do targeted therapies both promote resistance in cancer cells and evoke toxic side effects in patients?” The drug cocktails developed by the researchers are an advanced method of pushing current efforts using targeted therapies to treat patients. The method of attacking cancer growth from more than one area could increase the chance of success in more patients.
- Tirtha K. Das, MD, Assistant Professor, Cell, Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai